Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director Dealing

12 Dec 2013 13:31

RNS Number : 4092V
CVS Group plc
12 December 2013
 

12 December 2013

 

CVS Group plc

("CVS" or the "Company")

 

Director Dealing

 

CVS, the UK's leading provider of veterinary services, was notified today that on 11 December 2013, Simon Innes, Chief Executive Officer of the Company, sold 269,413 ordinary shares of 0.2 pence each in the Company ("Ordinary Shares"), at a price of 257 pence per share. This sale follows the exercise of options granted under the CVS Group Long Term Incentive Plan 2010/13, as announced on 5 December 2013.

 

Following the sale, Simon Innes remains interested in 546,475 Ordinary Shares in the Company, representing 0.95 per cent in the total voting rights of the Company.

 

 

 

Contacts:

 

CVS Group plc

Simon Innes, Chief Executive

Nick Perrin, Finance Director

 

Tel: 01379 644 288

 

N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell

Alex Wright

 

Tel: 020 7496 3000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEADAAFFNDFFF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.